1. Market Research
  2. > Therapy Industry

therapeutics Industry, September 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Diagnostics, Anti-Infective, Injectable Delivery, Pharmaceutical, Vaccine, Clinical Trial, Shampoo, Hospital, Autoimmune Disease, Cancer, Blood Disease, Healthcare, Deodorant, Cardiac Management, Biosimilar, Neurological Disorder, In Vitro Diagnostic Reagent, Psychotic Disorder, Hepatitis.


 
1-10 of about 1600 reports for therapeutics

Purchase Reports From Reputable Market Research Publishers

Fate Therapeutics Inc (FATE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • $ 1995
  • Company report
  • Sep 2017
  • by Plunkett Research

Fate Therapeutics Inc (FATE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: - Unique new report provides deep financial ...

Abeona Therapeutics Inc (ABEO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • $ 1995
  • Company report
  • November 2017
  • by Plunkett Research

Abeona Therapeutics Inc (ABEO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: - Unique new report provides deep financial ...

Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • $ 1995
  • Company report
  • November 2017
  • by Plunkett Research

Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: - Unique new report provides deep financial ...

Akebia Therapeutics Inc (AKBA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • $ 1995
  • Company report
  • November 2017
  • by Plunkett Research

Akebia Therapeutics Inc (AKBA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: - Unique new report provides deep financial ...

Amicus Therapeutics, Inc

  • $ 99
  • Company report
  • September 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Amicus Therapeutics, Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Heron Therapeutics Inc

  • $ 99
  • Company report
  • September 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Heron Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Cytomx Therapeutics Inc

  • $ 99
  • Company report
  • September 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Cytomx Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Silence Therapeutics Plc

  • $ 99
  • Company report
  • September 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Silence Therapeutics Plc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Summit Therapeutics PLC

  • $ 99
  • Company report
  • September 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Summit Therapeutics PLC compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Zelda Therapeutics Ltd

  • $ 99
  • Company report
  • September 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Zelda Therapeutics Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.